Press release – Lund, November 13th, 2026 – Hamlet BioPharma presented at Aktiespararna Life Science event on November 12th, 2026

Hamlet Biopharma
|
November 13, 2026

Hamlet BioPharma AB announces that the company presented at the Aktiespararna Life Science evening on November 12th, 2026.

Watch the presentation here: https://www.youtube.com/watch?v=KVbsDlGOc8U

 

For further information, please contact

Catharina Svanborg, Chairman and Founder of Hamlet BioPharma, +46-709 42 65 49

catharina.svanborg@hamletpharma.com

Jakob Testad, CEO, Hamlet BioPharma AB, +46 708 48 42 10,

jakob.testad@hamletbiopharma.com

www.hamletbiopharma.com

An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.
Hamlet BioPharma AB
Klinikgatan 32
SE-222 42 Lund
info@hamletbiopharma.com
Org. no. 556568-8958
Subscribe to receive
Pressreleases and Newsletters
© 2026
Hamlet BioPharma.